At a glance
- Originator Pharmacia Corporation
- Class Antidepressants; Antipsychotics; Benzonitrile; Small molecules
- Mechanism of Action Dopamine D2 receptor antagonists; Dopamine D3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Major depressive disorder; Schizophrenia; Substance-related disorders
Most Recent Events
- 11 Jan 1999 Discontinued-Preclinical for Substance-related disorders in USA (Unknown route)
- 10 Feb 1998 Discontinued-Preclinical for Depression in USA (Unknown route)
- 10 Feb 1998 Discontinued-Preclinical for Schizophrenia in USA (Unknown route)